Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype von Mitra, A, Fisher, C, Foster, C S, Jameson, C, Barbachanno, Y, Bartlett, J, Bancroft, E, Doherty, R, Kote-Jarai, Z, Peock, S, Easton, D, Eeles, R

Volltext